Doctors have successfully treated an infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer. The decision to use the drug, sorafenib, was made after pathologists identified a unique mutation of two genes being fused together instead of on separate chromosomes.
from Latest Science News -- ScienceDaily https://ift.tt/31e7ZxO
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment